@dwong47.bsky.social
Reposted
We’re proud that the @lifearc.bsky.social Centre for Rare Mitochondrial Diseases has officially launched at a prestigious House of Lords event – a significant milestone in transforming the UK’s rare disease research landscape
Stay tuned to meet the lead minds behind the centre on our Research Zone!
Stay tuned to meet the lead minds behind the centre on our Research Zone!
May 14, 2025 at 10:31 AM
We’re proud that the @lifearc.bsky.social Centre for Rare Mitochondrial Diseases has officially launched at a prestigious House of Lords event – a significant milestone in transforming the UK’s rare disease research landscape
Stay tuned to meet the lead minds behind the centre on our Research Zone!
Stay tuned to meet the lead minds behind the centre on our Research Zone!
🚨 Final call to register for the Cambridge Eye Trust Research Day!
🗓️ 17 June 2025 | 09:30–14:00
📍 Li Ka Shing Centre, Cambridge
🎤 Keynote: Prof David Huang – OCT: My Personal Journey to Discovery
👉 www.cambridgeeyetrust.org.uk/meeting-regi...
#Ophthalmology #OCT #VisionScience
🗓️ 17 June 2025 | 09:30–14:00
📍 Li Ka Shing Centre, Cambridge
🎤 Keynote: Prof David Huang – OCT: My Personal Journey to Discovery
👉 www.cambridgeeyetrust.org.uk/meeting-regi...
#Ophthalmology #OCT #VisionScience
Meeting registration | Cambridge Eye Trust
www.cambridgeeyetrust.org.uk
May 13, 2025 at 4:13 PM
🚨 Final call to register for the Cambridge Eye Trust Research Day!
🗓️ 17 June 2025 | 09:30–14:00
📍 Li Ka Shing Centre, Cambridge
🎤 Keynote: Prof David Huang – OCT: My Personal Journey to Discovery
👉 www.cambridgeeyetrust.org.uk/meeting-regi...
#Ophthalmology #OCT #VisionScience
🗓️ 17 June 2025 | 09:30–14:00
📍 Li Ka Shing Centre, Cambridge
🎤 Keynote: Prof David Huang – OCT: My Personal Journey to Discovery
👉 www.cambridgeeyetrust.org.uk/meeting-regi...
#Ophthalmology #OCT #VisionScience
Thanks to @lilyfoundation.bsky.social for an eye-opening #PPIE workshop, and to @lifearc.bsky.social for a really exciting day overall outlining research strategies and new collaborations!
Really excited to see the progress over the next few years!
@mitocamb.bsky.social
Really excited to see the progress over the next few years!
@mitocamb.bsky.social
Yesterday we were proud to join the launch of the LifeArc Centre for Rare Mitochondrial Diseases - a major step forward in mito research
We led a workshop on making complex science clear – because involving patients is key to success
#mitochondrialdisease #mitoresearch #patientvoice #raredisease
We led a workshop on making complex science clear – because involving patients is key to success
#mitochondrialdisease #mitoresearch #patientvoice #raredisease
April 16, 2025 at 7:52 AM
Thanks to @lilyfoundation.bsky.social for an eye-opening #PPIE workshop, and to @lifearc.bsky.social for a really exciting day overall outlining research strategies and new collaborations!
Really excited to see the progress over the next few years!
@mitocamb.bsky.social
Really excited to see the progress over the next few years!
@mitocamb.bsky.social
Reposted
2x CRA posts extended until end of April. So you have another chance to work with #mito disease patients as part of the @lifearc.bsky.social centre for #rare #mito diseases! See links below to apply!
@eastgenomics.bsky.social @camneuro.bsky.social @cuhnhs.bsky.social
@eastgenomics.bsky.social @camneuro.bsky.social @cuhnhs.bsky.social
📢 We have not 1 but 3 clinical/patient-facing jobs working with #mitoCAMB on the #LifeArc #raredisease centre for #mito diseases.
1x pre/post-doctoral CRA;
1x post-doctoral CRA (with potential to become a 4 year ACL); 1x research coordinator
Join us! Links below.
1x pre/post-doctoral CRA;
1x post-doctoral CRA (with potential to become a 4 year ACL); 1x research coordinator
Join us! Links below.
April 11, 2025 at 6:23 AM
2x CRA posts extended until end of April. So you have another chance to work with #mito disease patients as part of the @lifearc.bsky.social centre for #rare #mito diseases! See links below to apply!
@eastgenomics.bsky.social @camneuro.bsky.social @cuhnhs.bsky.social
@eastgenomics.bsky.social @camneuro.bsky.social @cuhnhs.bsky.social
Reposted
📢 We have not 1 but 3 clinical/patient-facing jobs working with #mitoCAMB on the #LifeArc #raredisease centre for #mito diseases.
1x pre/post-doctoral CRA;
1x post-doctoral CRA (with potential to become a 4 year ACL); 1x research coordinator
Join us! Links below.
1x pre/post-doctoral CRA;
1x post-doctoral CRA (with potential to become a 4 year ACL); 1x research coordinator
Join us! Links below.
February 28, 2025 at 10:56 AM
📢 We have not 1 but 3 clinical/patient-facing jobs working with #mitoCAMB on the #LifeArc #raredisease centre for #mito diseases.
1x pre/post-doctoral CRA;
1x post-doctoral CRA (with potential to become a 4 year ACL); 1x research coordinator
Join us! Links below.
1x pre/post-doctoral CRA;
1x post-doctoral CRA (with potential to become a 4 year ACL); 1x research coordinator
Join us! Links below.
Reposted
All the jobs, all in one place!!
February 28, 2025 at 2:42 PM
All the jobs, all in one place!!
Reposted
Some nice work with translational potential: links.springernature.com/f/a/GeMY0gc0...
Disruption of mitochondrial homeostasis and permeability transition pore opening in OPA1 iPSC-derived retinal ganglion cells - Acta Neuropathologica Communications
Dominant optic atrophy (DOA) is the most common inherited optic neuropathy, characterised by the selective loss of retinal ganglion cells (RGCs). Over 60% of DOA cases are caused by pathogenic variant...
links.springernature.com
February 13, 2025 at 4:26 PM
Some nice work with translational potential: links.springernature.com/f/a/GeMY0gc0...